Ticker Details
Sarepta Therapeutics, Inc. Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases.
IPO Date:	July 12, 2012
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.33B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.51 | 2.47%
Avg Daily Range (30 D):	$0.65 | 3.27%
Avg Daily Range (90 D):	$0.62 | 3.01%

Institutional Daily Volume
Avg Daily Volume:	1.83M
Avg Daily Volume (30 D):	2.75M
Avg Daily Volume (90 D):	2.46M

Trade Size
Avg Trade Size (Sh.):	105
Avg Trade Size (Sh.) (30 D):	73
Avg Trade Size (Sh.) (90 D):	71

Institutional Trades
Total Institutional Trades:	13,912
Avg Institutional Trade:	$4.04M
Avg Institutional Trade (30 D):	$3.24M
Avg Institutional Trade (90 D):	$3.5M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$8.75M
Avg Closing Trade (30 D):	$7.35M
Avg Closing Trade (90 D):	$7.62M
Avg Closing Volume:	127.01K

News

Mar 27, 2026 @ 5:09 PM Nasdaq 100 Enters Correction As 30-Year Yields Nea... Source: Piero Cingari

Jan 26, 2026 @ 1:41 PM Stock Market Today: Dow Futures Gain, S&P 500 Slip... Source: Rishabh Mishra

Jan 22, 2026 @ 3:30 AM 2 Beaten-Down Stocks That Could Sink Even More in ... Source: Prosper Junior Bakiny

Dec 24, 2025 @ 2:14 PM Silver Breaks Above $70, Novo Nordisk Soars 9% On ... Source: Piero Cingari

Nov 4, 2025 @ 5:11 PM Sarepta Stock Dumps: Pharma Bro Martin Shkreli Sti... Source: Erica Kollmann

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-7.13	$-3.93	$-7.13
Diluted EPS	$-7.13	$-3.93	$-7.13
Revenue	$2.2B	$442.93M	$2.2B
Gross Profit	$2.17B	$-29.1M	$2.17B
Net Income / Loss	$-713.41M	$-412.23M	$-713.41M
Operating Income / Loss	$-699.78M	$-411.58M	$-699.78M
Cost of Revenue	$25.5M	$472.04M	$25.5M
Net Cash Flow	$-304.18M	$188.21M	$-304.18M
PE Ratio

Splits
Jul 12, 2012	1:6